26.07.2013 Views

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

Untitled - D Ank Unlimited

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

heterophile antigen 324 high-dose tolerance<br />

unrelated species. The antibody is often an immunoglobulin<br />

M (IgM) agglutinin. Heterophile antibodies are detected<br />

in infectious mononucleosis patients who demonstrate<br />

antibodies reactive with sheep erythrocytes. To differentiate<br />

this condition from serum sickness, which also is associated<br />

with high titers of heterophile antibodies, the serum<br />

sample is absorbed with beef erythrocytes that contain<br />

Forssman antigen. This treatment removes the heterophile<br />

antibody reactivity from the sera of infectious mononucleosis<br />

patients.<br />

heterophile antigen<br />

An antigen (epitope) present in divergent animal species,<br />

plants, and bacteria that manifests broad cross reactivity<br />

with antibodies of the heterophile group. Heterophile<br />

antigens induce the formation of heterophile antibodies<br />

when introduced into a species in which they are absent.<br />

Heterophile antigens are often carbohydrates.<br />

heterospecific<br />

Showing specificity for a species other than the one from<br />

which the substance in question was derived.<br />

heterotopic<br />

The placement of an organ or tissue graft in an anatomic<br />

site other than the one where it is normally located.<br />

heterotopic graft<br />

A tissue or organ transplanted to an anatomic site other<br />

than the one where it is usually found under natural<br />

conditions—for example, the anastomosis of the renal<br />

vasculature at an anatomical site that would situate the<br />

kidney in a place other than the renal fossa, where it is<br />

customarily found.<br />

heterotypic vaccine<br />

Refer to heterologous vaccine.<br />

heterozygosity<br />

The presence of different alleles at one or more loci on<br />

homologous chromosomes.<br />

heterozygous<br />

Descriptor for individuals possessing two different alleles<br />

of a particular gene.<br />

HEV<br />

Refer to high endothelial venules.<br />

Hewson, William (1739–1774)<br />

British physician credited as the “father of hematology.”<br />

Heymann antigen<br />

A 330-kDa glycoprotein (GP330) present on visceral<br />

epithelial cell basal surfaces in coated pits and on tubular<br />

brush borders. It participates in production of experimental<br />

nephritis in rats. See also Heymann glomerulonephritis.<br />

Heymann glomerulonephritis<br />

An experimental model of membranous glomerulonephritis<br />

induced by immunizing rats with proximal tubule<br />

brush border preparations containing subepithelial antigen<br />

or Heymann factor, a 330-kDa protein incorporated in<br />

Freund’s adjuvant. The rats produce antibodies against<br />

brush border antigens and membranous glomerulonephritis<br />

is induced. Autoantibodies combine with shed epithelial<br />

cell antigen. The union of antibody with Heymann antigen,<br />

distributed in an interrupted manner along visceral epithelial<br />

cell surfaces, leads to subepithelial electron-dense,<br />

granular deposits. Immunoglobulins and complement are<br />

deposited in a granular rather than linear pattern along the<br />

glomerular basement membrane, as revealed by immunofluorescence.<br />

The glomerulonephritis results from interaction<br />

William Hewson.<br />

of anti-brush border antibody with the 330-kDa glycoprotein,<br />

which is fixed but discontinuously distributed on the<br />

bases of visceral epithelial cells and is cross reactive with<br />

brush border antigens. Heymann nephritis closely resembles<br />

human membranous glomerulonephritis.<br />

Heymann’s nephritis<br />

Refer to Heymann glomerulonephritis.<br />

HGG<br />

Abbreviation for human γ globulin.<br />

HGP-30<br />

An experimental vaccine for AIDS that employs a synthetic<br />

HIV core protein, p17.<br />

HHV<br />

Human herpesvirus.<br />

Hib (Hemophilus influenzae type b)<br />

A microorganism that induces infection, mostly in infants<br />

below 5 years of age. Approximately 1,000 deaths among<br />

20,000 annual cases are recorded. A polysaccharide vaccine<br />

(Hib Vac) was of only marginal efficacy and poorly<br />

immunogenic. By contrast, anti-Hib vaccine that contains<br />

capsular polysaccharide of Hib bound covalently to a carrier<br />

protein such as polyribosylribitol–diphtheria toxoid<br />

(PRP-D) induces a very high level of protection, for example,<br />

94% in one cohort of Finnish infants. PRP–tetanus<br />

toxoid has induced 75% protection, and PRP–diphtheria<br />

toxoid vaccine is claimed to be 88% effective.<br />

hidden determinant<br />

An epitope on a cell or molecule that is unavailable for interaction<br />

with either lymphocyte receptors or the antigen-binding<br />

region of antibody molecules because of stereochemical<br />

factors. These hidden or cryptic determinants neither<br />

react with lymphocyte or antibody receptors nor induce an<br />

immune response unless an alteration in the steric configuration<br />

of the molecule causes the epitope to be exposed.<br />

HIG<br />

Acronym for human immune globulin.<br />

high-dose tolerance<br />

Specific immunologic unresponsiveness induced by the<br />

repeated administration of large doses of antigen (tolerogen)<br />

if the substance is a protein or a massive single dose if the

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!